Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2005-10-25
2005-10-25
Kumar, Shailendra (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S098000, C564S099000, C514S601000, C514S605000, C514S352000, C514S471000, C514S419000, C546S304000, C548S483000, C549S480000
Reexamination Certificate
active
06958416
ABSTRACT:
The invention relates to derivatives of valproyltaurinamide of formula (I) in which R1and R2are independently hydrogen, a C1-C6-alkyl group, an arylalkyl group or an aryl group. The derivatives are especially useful for the treatment of epilepsy, affective illness, cognitive disorders, neurodegenerative disease, neuropathic pain syndrome, migraine, stroke, brain ischemia, or head trauma injury.
REFERENCES:
patent: 4556673 (1985-12-01), Andersen et al.
patent: 5585358 (1996-12-01), Bialer et al.
S. S. Oja et al.,Anticonvulsant Activity of Some 2-Aminoethanesulphonic Acid(Taurine)Derivatives, European Journal of Pharmacology, 1983, vol. 87, pp. 191-198.
L. Ahtee et al.,Comparison of Central nervous System Actions of Taurine and N-Plyaloyltaurine, Acta Pharmacol. et Toxicol. 1985, vol. 57, pp. 96-105.
B. W. Collins et al/.Plasma and Urinary Taurine in Epilepsy, Clinical Chemistry, 1988, vol. 34, No. 4, pp. 671-675.
Meir Bialer,Clinical Pharmacology of Valpromide, Clin. Pharmacokinet. 1991, vol. 20, pp. 114-122.
M. Bialer et al.,Progress Report on new antiepileptic drugs: a summary of the fourth Eilat conference(EILAT VI), Epilepsy Research, 1999, vol. 34, pp. 1-41.
N. Isoherranen et al.,Anticonvulsant activity, teratogenicity and pharmacokinetics of novel valproyltaurinamide derivatives in mice, British Journal of Pharmacology, 2003, vol. 139, pp. 755-764.
Bialer Meir
Isoherranen Nina
Yagen Boris
Browdy and Neimark PLLC
Kumar Shailendra
Yissum Research Development Company of the Hebrew University of
LandOfFree
Valproyltaurinamide derivatives as anticonvulsant amd CNS... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Valproyltaurinamide derivatives as anticonvulsant amd CNS..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Valproyltaurinamide derivatives as anticonvulsant amd CNS... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3464024